Literature DB >> 21940235

Cutaneous and systemic plasmacytosis vs. cutaneous plasmacytic castleman disease: review and speculations about pathogenesis.

Maryam Haque1, J Steve Hou, Katsuya Hisamichi, Koji Tamada, Carrie Ann Cusack, Mark Abdelmalek, Robert E Brown, Eric C Vonderheid.   

Abstract

Cutaneous and systemic plasmacytosis (C/SP), human herpes virus-8 (HHV8), negative multicentric plasmacytic Castleman disease (MPCD), and idiopathic plasmacytic lymphadenopathy are polyclonal plasma cell proliferations of unknown etiology that predominantly affect Asian individuals. Herein, we present our experience with a Vietnamese man with typical C/SP limited to the skin but, after 10 years, may have developed perirenal involvement, and with a white man with human immunodeficiency virus and HHV8 negative MPCD with involvement of skin, lymph nodes, and kidneys at presentation, and who later succumbed to gastric carcinoma. Based on a review of the literature, we suggest that C/SP, cutaneous MPCD, and idiopathic plasmacytic lymphadenopathy with skin involvement are part of a continuum rather than distinct entities and, as such, may be regarded as variants of HHV8-negative MPCD. Although the majority of patients with C/SP run a chronic benign course, special attention should be given to monitoring for pulmonary and renal involvement. We hypothesize that long-lived plasma cells originate and survive in the environment of the skin akin to other stromal "survival" niches due to the local production of interleukin 6 and that such patients might respond to agents that interfere with interleukin-6 activity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21940235     DOI: 10.1016/j.clml.2011.07.004

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN: 2152-2669


  11 in total

1.  Cutaneous and systemic plasmacytosis on the face: Effective treatment of a case using thalidomide.

Authors:  Sheng Fang; Kui Shan; Ai-Jun Chen
Journal:  Oncol Lett       Date:  2016-01-25       Impact factor: 2.967

2.  Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.

Authors:  Li Yu; Meifeng Tu; Jorge Cortes; Zijun Y Xu-Monette; Roberto N Miranda; Jun Zhang; Robert Z Orlowski; Sattva Neelapu; Prajwal C Boddu; Mary A Akosile; Thomas S Uldrick; Robert Yarchoan; L Jeffrey Medeiros; Yong Li; David C Fajgenbaum; Ken H Young
Journal:  Blood       Date:  2017-01-18       Impact factor: 22.113

3.  Focal segmental glomerulosclerosis associated with cutaneous and systemic plasmacytosis.

Authors:  Shinsuke Isobe; Naro Ohashi; Naoko Katahashi; Sayaka Ishigaki; Naoko Tsuji; Takayuki Tsuji; Akihiko Kato; Yoshihide Fujigaki; Akira Shimizu; Hideo Yasuda
Journal:  CEN Case Rep       Date:  2017-09-22

4.  Cutaneous Plasmacytosis Associated with Ehrlichiosis in an African-American Patient.

Authors:  Luke Maxfield; Jarett Casale; Muneeb Shah; Mikél E Muse; Dana Baigrie
Journal:  J Clin Aesthet Dermatol       Date:  2021-03-01

5.  Cutaneous plasmacytosis resembling pityriasis rosea in a 66-year-old white woman: A rare disease presenting in an unusual patient demographic.

Authors:  Jennifer Bares; Apphia Wang; Peter Pavlidakey; Diego De Idiaquez Bakula; Boni Elewski
Journal:  JAAD Case Rep       Date:  2017-02-04

6.  Cutaneous Plasmacytosis Showing a Neuronal Involvement in a 35-Year-Old Female.

Authors:  Joong-Heon Suh; Ho-Young Kim; Jae Ho Lee; Soo-Kyung Lee; Un-Ha Lee; Myoung-Shin Kim
Journal:  Ann Dermatol       Date:  2020-03-11       Impact factor: 1.444

7.  A case of cutaneous plasmacytosis.

Authors:  Jian-Xin Xia; Fu-Qiu Li; Ming Zhang; Yan Mou; Jin-Feng Wang; Xiang-Lin Mei; Xue Li; Wen-Jing Zhu
Journal:  Exp Ther Med       Date:  2013-01-25       Impact factor: 2.447

8.  Canine Cutaneous Plasmacytosis: 21 Cases (2005-2015).

Authors:  B O Boostrom; A S Moore; C J DeRegis; C Robat; K Freeman; D H Thamm
Journal:  J Vet Intern Med       Date:  2017-05-17       Impact factor: 3.333

9.  Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report.

Authors:  Ping-Yang Han; Hui-Hui Chi; Yu-Tong Su
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

10.  Non Epitheliotropic B-Cell Lymphoma with Plasmablastic Differentiation vs. Cutaneous Plasmacytosis in a 12-Years-Old Beagle: Case Presentation and Clinical Review.

Authors:  Maria Teresa Antognoni; Ambra Lisa Misia; Chiara Brachelente; Luca Mechelli; Andrea Paolini; Arianna Miglio
Journal:  Vet Sci       Date:  2021-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.